STEREOTAXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.18 USD | -0.46% |
|
-6.84% | +24.57% |
| Mar. 04 | Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024 | |
| Mar. 04 | Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M | MT |
Presentation Operator MessageOperator (Operator)Welcome to the Stereotaxis Innovation Day, Pio...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Companyâs primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Calendar
2024-05-12
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.18
USD
Average target price
4.5
USD
Spread / Average Target
+106.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.57% | 179M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- STXS Stock
- News Stereotaxis, Inc.
- Transcript : Stereotaxis, Inc. - Special Call
